The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Evolving knowledge of the teratogenicity of medications in human pregnancy
Abstract
A majority of pregnant women take at least one medication during pregnancy, although the safety of such drugs during pregnancy is not always known. We reviewed the safety during pregnancy of 172 drugs approved by the US Food and Drug Administration (FDA) from 2000 to 2010 using the TERIS risk rating system. We also reviewed safety information for 468 drugs approved by the FDA from 1980 to 2000 to determine if revisions in risk categories had been made in the last 10 years. The teratogenic risk in human pregnancy was “undetermined” for 168 (97.7%) of drug treatments approved between 2000 and 2010. Furthermore, the amount of data available regarding safety in pregnancy was rated as “none” for 126 (73.3%) of these drugs. For those drugs approved between 1980 and 2000, only 23 (5%) changed a full risk category or more in the past 10 years. Sources of data that led to a revised risk were derived from exposure cohort studies performed through record linkage studies, teratogen information services, large population‐based case‐control studies, and pregnancy registries. The mean time for a treatment initially classified as having an “undetermined” risk to be assigned a more precise risk was 27 years (95% confidence interval 26–28 years). The lack of information needed to assess the safety of drug treatments during human pregnancy remains a serious public health problem. A more active approach to post‐marketing surveillance for teratogenic effects is necessary. © 2011 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical Methods for Rates and Proportions.
Everitt, B. S., & Fleiss, J. L. (1981) · Biometrics · doi:10.2307/2530193 · Cited by 8,990
Major congenital malformations after first-trimester exposure to ACE inhibitors
Cooper, W. O., Hernandez-Diaz, S., Arbogast, P. G., Dudley, J. A., Dyer, S., Gideon, P. S., Hall, K., & Ray, W. A. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055202 · Cited by 1,192
Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008
Mitchell, A. A., Gilboa, S. M., Werler, M. M., Kelley, K. E., Louik, C., & Hernández-Díaz, S. (2011) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2011.02.029 · Cited by 813
The National Birth Defects Prevention Study
Yoon, P., Rasmussen, S., Lynberg, M., Moore, C., Anderka, M., Carmichael, S., Costa, P., Druschel, C., Hobbs, C., Romitti, P., et al. (2001) · Public Health Reports® · doi:10.1093/phr/116.s1.32 · Cited by 692
Prescription drug use in pregnancy
Andrade, S. E., Gurwitz, J. H., Davis, R. L., Chan, K. A., Finkelstein, J. A., Fortman, K., McPhillips, H., Raebel, M. A., Roblin, D., Smith, D. H., et al. (2004) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.04.025 · Cited by 564
Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk
Gilbert-Barness, E. (1996) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.1996.02170300118039 · Cited by 459
Use of over-the-counter medications during pregnancy
Werler, M. M., Study, T. N. B. D. P., Mitchell, A. A., Hernandez-Diaz, S., & Honein, M. A. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2005.02.100 · Cited by 380
Angiotensin II receptor antagonist treatment during pregnancy
Alwan, S., Polifka, J. E., & Friedman, J. M. (2005) · Birth Defects Research Part A: Clinical and Molecular Teratology · doi:10.1002/bdra.20102 · Cited by 247
Self-citationChemically Induced Birth Defects
Schardein, J. (2000) · CRC Press eBooks · doi:10.3109/9780203909904 · Cited by 242
Drugs During Pregnancy and Lactation: Treatment Options and Risk Assessment
Schaefer, C. E., Peters, P. W. J., & Miller, R. K. (2011) · Cited by 205
Cited by
Prenatal paracetamol exposure and child neurodevelopment: A review
Bauer, A. Z., Kriebel, D., Herbert, M. R., Bornehag, C.-G., & Swan, S. H. (2018) · Hormones and Behavior · doi:10.1016/j.yhbeh.2018.01.003 · Cited by 127
Metadata
- Authors
- Adam, M. P., Polifka, J. E., & Friedman, J. M.
- Venue
- American Journal of Medical Genetics Part C: Seminars in Medical Genetics
- Publisher
- Wiley
- Published
- 2011-07-15
- Volume
- 157
- Issue
- 3
- Pages
- 175-182
- ISSN
- 1552-4868 (ISSN-L)
- 1552-4876
- OpenAlex
- W2056105302
- Cited by
- 376
- References
- 23
- FWCI
- 14.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Evolving knowledge of the teratogenicity of medications in human pregnancy. https://app.cochat.ai/papers/10.1002/ajmg.c.30313
- The paper
- Adam, M. P., Polifka, J. E., & Friedman, J. M. (2011). Evolving knowledge of the teratogenicity of medications in human pregnancy. American Journal of Medical Genetics Part C: Seminars in Medical Genetics. https://doi.org/10.1002/ajmg.c.30313
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.